Personalized therapeutic approaches for improved glycemic outcomes in type 2 diabetes

doi:10.4239/wjd.v16.i5.104841

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=0

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

May 15, 2025 (publication date) through Apr 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Diabetes. May 15, 2025; 16(5): 104841
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.104841

Personalized therapeutic approaches for improved glycemic outcomes in type 2 diabetes

Eguono Deborah Akpoveta, Uchenna E Okpete, Haewon Byeon

Eguono Deborah Akpoveta, Department of Community Medicine, Federal Medical Centre, Asaba 322022, Delta state, Nigeria

Uchenna E Okpete, Department of Digital Anti-aging Healthcare (BK21), Inje University, Gimhae 50834, South Korea

Haewon Byeon, Department of Future Technology, Korea University of Technology and Education, Cheonan 31253, South Korea

Co-first authors: Eguono Deborah Akpoveta and Uchenna E Okpete.

Author contributions: Akpoveta ED, Okpete UE, and Byeon H contributed to this paper and assisted with writing the article; Byeon H designed the study; Akpoveta ED and Okpete UE were involved in data interpretation, developed methodology, and contributed equally as co-first authors.

Supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, No. NRF-RS-2023-00237287.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Haewon Byeon, PhD, Academic Editor, Associate Professor, Department of Future Technology, Korea University of Technology and Education, 1600 Chungjeol-ro, Byeongcheon-myeon, Dongnam-gu, Cheonan-si, Chungcheongnam-do, Cheonan 31253, South Korea. bhwpuma@naver.com

Received: January 6, 2025
Revised: February 23, 2025
Accepted: March 11, 2025
Published online: May 15, 2025
Processing time: 112 Days and 2.7 Hours

Core Tip

Core Tip: Effective diabetes management requires personalized approaches tailored to patients’ glycemic histories. Newly diagnosed individuals show the greatest potential for achieving glycemic targets, while persistently poorly controlled patients face significant challenges. Addressing therapeutic inertia and adopting patient-centered strategies are essential to improve outcomes and bridge gaps in real-world diabetes care.